TLK-286

Claire F. Verschraegen; Harriet O. Smith; Fa Chyi Lee; Cynthia Cathcart; Jeffery P. Norenberg

TLK-286

Claire F. Verschraegen, Harriet O. Smith, Fa Chyi Lee, Cynthia Cathcart, Jeffery P. Norenberg

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

Telik Inc is developing TLK-286, a modified glutathione analog prodrug, for the potential treatment of cancer.

Original language	English (US)
Pages (from-to)	771-781
Number of pages	11
Journal	IDrugs
Volume	7
Issue number	8
State	Published - Aug 2004
Externally published	Yes

ASJC Scopus subject areas

Pharmacology
Drug Discovery

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{f01807d6e67b433e88381d87a50f03c4,

title = "TLK-286",

abstract = "Telik Inc is developing TLK-286, a modified glutathione analog prodrug, for the potential treatment of cancer.",

author = "Verschraegen, {Claire F.} and Smith, {Harriet O.} and Lee, {Fa Chyi} and Cynthia Cathcart and Norenberg, {Jeffery P.}",

year = "2004",

month = aug,

language = "English (US)",

volume = "7",

pages = "771--781",

journal = "IDrugs",

issn = "1369-7056",

publisher = "Current Drugs Ltd.",

number = "8",

}

TY - JOUR

T1 - TLK-286

AU - Verschraegen, Claire F.

AU - Smith, Harriet O.

AU - Lee, Fa Chyi

AU - Cathcart, Cynthia

AU - Norenberg, Jeffery P.

PY - 2004/8

Y1 - 2004/8

N2 - Telik Inc is developing TLK-286, a modified glutathione analog prodrug, for the potential treatment of cancer.

AB - Telik Inc is developing TLK-286, a modified glutathione analog prodrug, for the potential treatment of cancer.

UR - http://www.scopus.com/inward/record.url?scp=16544388297&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16544388297&partnerID=8YFLogxK

M3 - Article

C2 - 15334311

AN - SCOPUS:16544388297

SN - 1369-7056

VL - 7

SP - 771

EP - 781

JO - IDrugs

JF - IDrugs

IS - 8

ER -

TLK-286

Abstract

ASJC Scopus subject areas

UN SDGs

Other files and links

Fingerprint

Cite this